Figure 1From: Antineoplastic effect of iodine in mammary cancer: participation of 6-iodolactone (6-IL) and peroxisome proliferator-activated receptors (PPAR)Chromatographic analyzes. Quantification by HPLC of arachidonic acid (AA) content and 6-iodolactone (6-IL) formation in normal (MG) or tumoral (Tumor) mammary glands from rats with or without molecular iodine supplements. A, representative chromatograms; a) base line, b) standards, c) MG control, d) MG +I2, e) tumor, f) tumor + I2. B, quantification; data are expressed as the mean ± SD (n = 10). Differences between experimental groups were analyzed using a one-way ANOVA and the Tukey-HSD Test. *indicates significant difference from the appropriate control (p < 0.05)Back to article page